Consumer products behemoth Proctor & Gamble (NYSE:PG) in Q1 CY2026, with sales up 7.4% year on year to $21.24 billion. Its non-GAAP profit of $1.59 per share was 2.2% above analysts’ consensus ...
Consumer products behemoth Proctor & Gamble (NYSE:PG) in Q4 CY2025, with sales up 1.5% year on year to $22.21 billion. Its non-GAAP profit of $1.88 per share was 1.2% above analysts’ consensus ...
Procter & Gamble managed to boost its net sales by 2% year over year during the quarter to just under $21.9 billion. On a non-GAAP (adjusted) basis, what the company calls its "core" earnings landed ...
Procter & Gamble Co. said it’s open to an acquisition in the consumer health care category, citing its successful purchase of a Merck business unit in 2018. “There are a couple of categories that we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results